nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Dexamethasone—multiple sclerosis	0.137	0.467	CbGbCtD
Eprosartan—ABCC2—Methotrexate—multiple sclerosis	0.11	0.376	CbGbCtD
Eprosartan—CYP2C9—Dexamethasone—multiple sclerosis	0.0461	0.157	CbGbCtD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00615	0.0347	CbGpPWpGaD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00615	0.0347	CbGpPWpGaD
Eprosartan—ABCC2—Irinotecan Pathway—BCHE—multiple sclerosis	0.00545	0.0307	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—C4A—multiple sclerosis	0.00427	0.024	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CCR1—multiple sclerosis	0.00367	0.0207	CbGpPWpGaD
Eprosartan—ABCC2—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00351	0.0197	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CXCL13—multiple sclerosis	0.00348	0.0196	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL12A—multiple sclerosis	0.00348	0.0196	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.00317	0.0178	CbGpPWpGaD
Eprosartan—AGTR1—Arf6 trafficking events—ITGA4—multiple sclerosis	0.00316	0.0178	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—FOXP3—multiple sclerosis	0.00299	0.0168	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-G—multiple sclerosis	0.00271	0.0153	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.0027	0.0152	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.0027	0.0152	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CXCR3—multiple sclerosis	0.00243	0.0137	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CCR2—multiple sclerosis	0.00236	0.0133	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL17A—multiple sclerosis	0.00235	0.0132	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD28—multiple sclerosis	0.00228	0.0129	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—TGFB1—multiple sclerosis	0.00223	0.0125	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL12B—multiple sclerosis	0.00219	0.0123	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.00217	0.0122	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD40—multiple sclerosis	0.00209	0.0117	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CTLA4—multiple sclerosis	0.00206	0.0116	CbGpPWpGaD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00201	0.0113	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00191	0.0108	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.00181	0.0102	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR1—multiple sclerosis	0.00172	0.00972	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL13—multiple sclerosis	0.00172	0.00972	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00172	0.00966	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00172	0.00966	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.00171	0.00962	CbGpPWpGaD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00169	0.00954	CbGpPWpGaD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00169	0.00954	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.00169	0.00953	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD86—multiple sclerosis	0.00163	0.00918	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD40LG—multiple sclerosis	0.0016	0.009	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL10—multiple sclerosis	0.0016	0.009	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00157	0.00884	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL4—multiple sclerosis	0.00155	0.00876	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CCR5—multiple sclerosis	0.00152	0.00858	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-B—multiple sclerosis	0.00152	0.00856	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00148	0.00832	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—FAS—multiple sclerosis	0.00143	0.00807	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL2RA—multiple sclerosis	0.00142	0.00802	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-A—multiple sclerosis	0.00141	0.00793	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00139	0.00783	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00139	0.00783	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00135	0.00761	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DRB1—multiple sclerosis	0.00129	0.00725	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00127	0.00713	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL3—multiple sclerosis	0.00123	0.00692	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—S1PR1—multiple sclerosis	0.0012	0.00673	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD80—multiple sclerosis	0.00119	0.0067	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00116	0.00652	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00116	0.00652	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.00114	0.00644	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.00111	0.00626	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—GPR65—multiple sclerosis	0.000963	0.00543	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IFNG—multiple sclerosis	0.00094	0.00529	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000926	0.00522	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.000924	0.0052	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK1—multiple sclerosis	0.000921	0.00519	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000895	0.00504	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000884	0.00498	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL13—multiple sclerosis	0.000881	0.00496	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCR1—multiple sclerosis	0.000881	0.00496	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—multiple sclerosis	0.000877	0.00494	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00087	0.0049	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL1B—multiple sclerosis	0.000838	0.00472	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL2—multiple sclerosis	0.000835	0.0047	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000824	0.00464	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000803	0.00452	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.000795	0.00448	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000794	0.00447	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000766	0.00432	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000746	0.0042	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000739	0.00416	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000739	0.00416	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000729	0.0041	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000729	0.0041	CbGpPWpGaD
Eprosartan—Angioedema—Methylprednisolone—multiple sclerosis	0.000722	0.00137	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.000716	0.00403	CbGpPWpGaD
Eprosartan—Malaise—Triamcinolone—multiple sclerosis	0.000714	0.00135	CcSEcCtD
Eprosartan—Malaise—Methylprednisolone—multiple sclerosis	0.000712	0.00135	CcSEcCtD
Eprosartan—Vertigo—Triamcinolone—multiple sclerosis	0.000711	0.00135	CcSEcCtD
Eprosartan—Syncope—Triamcinolone—multiple sclerosis	0.00071	0.00134	CcSEcCtD
Eprosartan—Vertigo—Methylprednisolone—multiple sclerosis	0.00071	0.00134	CcSEcCtD
Eprosartan—Syncope—Methylprednisolone—multiple sclerosis	0.000708	0.00134	CcSEcCtD
Eprosartan—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000706	0.00134	CcSEcCtD
Eprosartan—Dizziness—Azathioprine—multiple sclerosis	0.000701	0.00133	CcSEcCtD
Eprosartan—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.0007	0.00132	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000697	0.00132	CcSEcCtD
Eprosartan—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000696	0.00132	CcSEcCtD
Eprosartan—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000694	0.00131	CcSEcCtD
Eprosartan—Shock—Prednisolone—multiple sclerosis	0.000691	0.00131	CcSEcCtD
Eprosartan—Cough—Triamcinolone—multiple sclerosis	0.000691	0.00131	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000688	0.00388	CbGpPWpGaD
Eprosartan—Tachycardia—Prednisolone—multiple sclerosis	0.000686	0.0013	CcSEcCtD
Eprosartan—Urticaria—Mitoxantrone—multiple sclerosis	0.00068	0.00129	CcSEcCtD
Eprosartan—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000679	0.00129	CcSEcCtD
Eprosartan—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000677	0.00128	CcSEcCtD
Eprosartan—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000677	0.00128	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000675	0.0038	CbGpPWpGaD
Eprosartan—Myalgia—Triamcinolone—multiple sclerosis	0.000674	0.00128	CcSEcCtD
Eprosartan—Vomiting—Azathioprine—multiple sclerosis	0.000674	0.00127	CcSEcCtD
Eprosartan—Arthralgia—Methylprednisolone—multiple sclerosis	0.000673	0.00127	CcSEcCtD
Eprosartan—Myalgia—Methylprednisolone—multiple sclerosis	0.000673	0.00127	CcSEcCtD
Eprosartan—Anxiety—Methylprednisolone—multiple sclerosis	0.00067	0.00127	CcSEcCtD
Eprosartan—Rash—Azathioprine—multiple sclerosis	0.000668	0.00126	CcSEcCtD
Eprosartan—Dermatitis—Azathioprine—multiple sclerosis	0.000667	0.00126	CcSEcCtD
Eprosartan—Depression—Methotrexate—multiple sclerosis	0.000667	0.00126	CcSEcCtD
Eprosartan—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000667	0.00126	CcSEcCtD
Eprosartan—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000667	0.00126	CcSEcCtD
Eprosartan—Discomfort—Triamcinolone—multiple sclerosis	0.000666	0.00126	CcSEcCtD
Eprosartan—Discomfort—Methylprednisolone—multiple sclerosis	0.000664	0.00126	CcSEcCtD
Eprosartan—Headache—Azathioprine—multiple sclerosis	0.000664	0.00126	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000661	0.00372	CbGpPWpGaD
Eprosartan—Dry mouth—Triamcinolone—multiple sclerosis	0.000659	0.00125	CcSEcCtD
Eprosartan—Renal failure—Methotrexate—multiple sclerosis	0.000658	0.00124	CcSEcCtD
Eprosartan—Angioedema—Dexamethasone—multiple sclerosis	0.000656	0.00124	CcSEcCtD
Eprosartan—Angioedema—Betamethasone—multiple sclerosis	0.000656	0.00124	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—TGFB1—multiple sclerosis	0.000651	0.00367	CbGpPWpGaD
Eprosartan—Conjunctivitis—Methotrexate—multiple sclerosis	0.00065	0.00123	CcSEcCtD
Eprosartan—Malaise—Betamethasone—multiple sclerosis	0.000648	0.00123	CcSEcCtD
Eprosartan—Malaise—Dexamethasone—multiple sclerosis	0.000648	0.00123	CcSEcCtD
Eprosartan—Vertigo—Dexamethasone—multiple sclerosis	0.000645	0.00122	CcSEcCtD
Eprosartan—Vertigo—Betamethasone—multiple sclerosis	0.000645	0.00122	CcSEcCtD
Eprosartan—Syncope—Betamethasone—multiple sclerosis	0.000644	0.00122	CcSEcCtD
Eprosartan—Syncope—Dexamethasone—multiple sclerosis	0.000644	0.00122	CcSEcCtD
Eprosartan—Haematuria—Methotrexate—multiple sclerosis	0.000638	0.00121	CcSEcCtD
Eprosartan—Shock—Triamcinolone—multiple sclerosis	0.000636	0.0012	CcSEcCtD
Eprosartan—Insomnia—Prednisolone—multiple sclerosis	0.000635	0.0012	CcSEcCtD
Eprosartan—Shock—Methylprednisolone—multiple sclerosis	0.000634	0.0012	CcSEcCtD
Eprosartan—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000631	0.00119	CcSEcCtD
Eprosartan—Loss of consciousness—Betamethasone—multiple sclerosis	0.000631	0.00119	CcSEcCtD
Eprosartan—Epistaxis—Methotrexate—multiple sclerosis	0.000631	0.00119	CcSEcCtD
Eprosartan—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000631	0.00119	CcSEcCtD
Eprosartan—Paraesthesia—Prednisolone—multiple sclerosis	0.000631	0.00119	CcSEcCtD
Eprosartan—Tachycardia—Triamcinolone—multiple sclerosis	0.000631	0.00119	CcSEcCtD
Eprosartan—Nausea—Azathioprine—multiple sclerosis	0.000629	0.00119	CcSEcCtD
Eprosartan—Tachycardia—Methylprednisolone—multiple sclerosis	0.000629	0.00119	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCL3—multiple sclerosis	0.000628	0.00354	CbGpPWpGaD
Eprosartan—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000625	0.00118	CcSEcCtD
Eprosartan—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000623	0.00118	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00062	0.00349	CbGpPWpGaD
Eprosartan—Asthenia—Mitoxantrone—multiple sclerosis	0.000614	0.00116	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000613	0.00345	CbGpPWpGaD
Eprosartan—Myalgia—Dexamethasone—multiple sclerosis	0.000612	0.00116	CcSEcCtD
Eprosartan—Myalgia—Betamethasone—multiple sclerosis	0.000612	0.00116	CcSEcCtD
Eprosartan—Anxiety—Betamethasone—multiple sclerosis	0.000609	0.00115	CcSEcCtD
Eprosartan—Anxiety—Dexamethasone—multiple sclerosis	0.000609	0.00115	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—TNF—multiple sclerosis	0.000608	0.00343	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000604	0.0034	CbGpPWpGaD
Eprosartan—Discomfort—Betamethasone—multiple sclerosis	0.000604	0.00114	CcSEcCtD
Eprosartan—Discomfort—Dexamethasone—multiple sclerosis	0.000604	0.00114	CcSEcCtD
Eprosartan—Hypotension—Methylprednisolone—multiple sclerosis	0.000602	0.00114	CcSEcCtD
Eprosartan—Pain—Prednisolone—multiple sclerosis	0.000601	0.00114	CcSEcCtD
Eprosartan—Pharyngitis—Methotrexate—multiple sclerosis	0.000596	0.00113	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000589	0.00111	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000587	0.00111	CcSEcCtD
Eprosartan—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000586	0.00111	CcSEcCtD
Eprosartan—Insomnia—Triamcinolone—multiple sclerosis	0.000584	0.00111	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000584	0.00329	CbGpPWpGaD
Eprosartan—Insomnia—Methylprednisolone—multiple sclerosis	0.000583	0.0011	CcSEcCtD
Eprosartan—Ill-defined disorder—Prednisone—multiple sclerosis	0.00058	0.0011	CcSEcCtD
Eprosartan—Paraesthesia—Triamcinolone—multiple sclerosis	0.00058	0.0011	CcSEcCtD
Eprosartan—Feeling abnormal—Prednisolone—multiple sclerosis	0.000579	0.0011	CcSEcCtD
Eprosartan—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000579	0.0011	CcSEcCtD
Eprosartan—Visual impairment—Methotrexate—multiple sclerosis	0.000579	0.00109	CcSEcCtD
Eprosartan—Shock—Dexamethasone—multiple sclerosis	0.000577	0.00109	CcSEcCtD
Eprosartan—Shock—Betamethasone—multiple sclerosis	0.000577	0.00109	CcSEcCtD
Eprosartan—Dyspnoea—Triamcinolone—multiple sclerosis	0.000576	0.00109	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000574	0.00323	CbGpPWpGaD
Eprosartan—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000574	0.00109	CcSEcCtD
Eprosartan—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000574	0.00109	CcSEcCtD
Eprosartan—Tachycardia—Dexamethasone—multiple sclerosis	0.000572	0.00108	CcSEcCtD
Eprosartan—Tachycardia—Betamethasone—multiple sclerosis	0.000572	0.00108	CcSEcCtD
Eprosartan—Angioedema—Prednisone—multiple sclerosis	0.000572	0.00108	CcSEcCtD
Eprosartan—Dyspepsia—Triamcinolone—multiple sclerosis	0.000569	0.00108	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCR2—multiple sclerosis	0.000568	0.0032	CbGpPWpGaD
Eprosartan—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000567	0.00107	CcSEcCtD
Eprosartan—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000567	0.00107	CcSEcCtD
Eprosartan—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000567	0.00107	CcSEcCtD
Eprosartan—Malaise—Prednisone—multiple sclerosis	0.000564	0.00107	CcSEcCtD
Eprosartan—Vertigo—Prednisone—multiple sclerosis	0.000562	0.00106	CcSEcCtD
Eprosartan—Syncope—Prednisone—multiple sclerosis	0.000561	0.00106	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000561	0.00316	CbGpPWpGaD
Eprosartan—Tinnitus—Methotrexate—multiple sclerosis	0.00056	0.00106	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00056	0.00315	CbGpPWpGaD
Eprosartan—Anorexia—Dexamethasone—multiple sclerosis	0.000559	0.00106	CcSEcCtD
Eprosartan—Anorexia—Betamethasone—multiple sclerosis	0.000559	0.00106	CcSEcCtD
Eprosartan—Urticaria—Prednisolone—multiple sclerosis	0.000558	0.00106	CcSEcCtD
Eprosartan—Fatigue—Triamcinolone—multiple sclerosis	0.000557	0.00105	CcSEcCtD
Eprosartan—Fatigue—Methylprednisolone—multiple sclerosis	0.000556	0.00105	CcSEcCtD
Eprosartan—Pain—Triamcinolone—multiple sclerosis	0.000553	0.00105	CcSEcCtD
Eprosartan—Loss of consciousness—Prednisone—multiple sclerosis	0.00055	0.00104	CcSEcCtD
Eprosartan—Hypotension—Betamethasone—multiple sclerosis	0.000548	0.00104	CcSEcCtD
Eprosartan—Hypotension—Dexamethasone—multiple sclerosis	0.000548	0.00104	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000548	0.00309	CbGpPWpGaD
Eprosartan—Vomiting—Mitoxantrone—multiple sclerosis	0.000545	0.00103	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000544	0.00307	CbGpPWpGaD
Eprosartan—Rash—Mitoxantrone—multiple sclerosis	0.00054	0.00102	CcSEcCtD
Eprosartan—Dermatitis—Mitoxantrone—multiple sclerosis	0.000539	0.00102	CcSEcCtD
Eprosartan—Chills—Methotrexate—multiple sclerosis	0.000539	0.00102	CcSEcCtD
Eprosartan—Headache—Mitoxantrone—multiple sclerosis	0.000537	0.00102	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000534	0.00101	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000534	0.00101	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000533	0.003	CbGpPWpGaD
Eprosartan—Arthralgia—Prednisone—multiple sclerosis	0.000533	0.00101	CcSEcCtD
Eprosartan—Myalgia—Prednisone—multiple sclerosis	0.000533	0.00101	CcSEcCtD
Eprosartan—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000532	0.00101	CcSEcCtD
Eprosartan—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000531	0.00101	CcSEcCtD
Eprosartan—Anxiety—Prednisone—multiple sclerosis	0.000531	0.001	CcSEcCtD
Eprosartan—Insomnia—Dexamethasone—multiple sclerosis	0.00053	0.001	CcSEcCtD
Eprosartan—Insomnia—Betamethasone—multiple sclerosis	0.00053	0.001	CcSEcCtD
Eprosartan—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000527	0.000997	CcSEcCtD
Eprosartan—Paraesthesia—Betamethasone—multiple sclerosis	0.000526	0.000996	CcSEcCtD
Eprosartan—Paraesthesia—Dexamethasone—multiple sclerosis	0.000526	0.000996	CcSEcCtD
Eprosartan—Discomfort—Prednisone—multiple sclerosis	0.000526	0.000996	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CNR1—multiple sclerosis	0.000524	0.00295	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RGS1—multiple sclerosis	0.000521	0.00294	CbGpPWpGaD
Eprosartan—Hypersensitivity—Prednisolone—multiple sclerosis	0.000518	0.000979	CcSEcCtD
Eprosartan—Dyspepsia—Dexamethasone—multiple sclerosis	0.000516	0.000976	CcSEcCtD
Eprosartan—Dyspepsia—Betamethasone—multiple sclerosis	0.000516	0.000976	CcSEcCtD
Eprosartan—Urticaria—Triamcinolone—multiple sclerosis	0.000513	0.000971	CcSEcCtD
Eprosartan—Urticaria—Methylprednisolone—multiple sclerosis	0.000512	0.000969	CcSEcCtD
Eprosartan—Body temperature increased—Triamcinolone—multiple sclerosis	0.000511	0.000966	CcSEcCtD
Eprosartan—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00051	0.000964	CcSEcCtD
Eprosartan—Decreased appetite—Betamethasone—multiple sclerosis	0.00051	0.000964	CcSEcCtD
Eprosartan—Decreased appetite—Dexamethasone—multiple sclerosis	0.00051	0.000964	CcSEcCtD
Eprosartan—Nausea—Mitoxantrone—multiple sclerosis	0.000509	0.000962	CcSEcCtD
Eprosartan—Back pain—Methotrexate—multiple sclerosis	0.000506	0.000957	CcSEcCtD
Eprosartan—Fatigue—Betamethasone—multiple sclerosis	0.000505	0.000956	CcSEcCtD
Eprosartan—Fatigue—Dexamethasone—multiple sclerosis	0.000505	0.000956	CcSEcCtD
Eprosartan—Shock—Prednisone—multiple sclerosis	0.000502	0.00095	CcSEcCtD
Eprosartan—Pain—Betamethasone—multiple sclerosis	0.000501	0.000948	CcSEcCtD
Eprosartan—Pain—Dexamethasone—multiple sclerosis	0.000501	0.000948	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000501	0.00282	CbGpPWpGaD
Eprosartan—Tachycardia—Prednisone—multiple sclerosis	0.000498	0.000943	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000498	0.0028	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000498	0.0028	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GPR65—multiple sclerosis	0.000494	0.00278	CbGpPWpGaD
Eprosartan—Hyperhidrosis—Prednisone—multiple sclerosis	0.000494	0.000934	CcSEcCtD
Eprosartan—Anorexia—Prednisone—multiple sclerosis	0.000487	0.000921	CcSEcCtD
Eprosartan—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000485	0.000918	CcSEcCtD
Eprosartan—Feeling abnormal—Betamethasone—multiple sclerosis	0.000483	0.000914	CcSEcCtD
Eprosartan—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000483	0.000914	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00048	0.00271	CbGpPWpGaD
Eprosartan—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000479	0.000907	CcSEcCtD
Eprosartan—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000479	0.000907	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—LINGO1—multiple sclerosis	0.000478	0.00269	CbGpPWpGaD
Eprosartan—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000476	0.000901	CcSEcCtD
Eprosartan—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000475	0.000899	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000472	0.00266	CbGpPWpGaD
Eprosartan—Malaise—Methotrexate—multiple sclerosis	0.000471	0.000892	CcSEcCtD
Eprosartan—Vertigo—Methotrexate—multiple sclerosis	0.00047	0.000889	CcSEcCtD
Eprosartan—Urticaria—Dexamethasone—multiple sclerosis	0.000466	0.000881	CcSEcCtD
Eprosartan—Urticaria—Betamethasone—multiple sclerosis	0.000466	0.000881	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000465	0.00088	CcSEcCtD
Eprosartan—Dizziness—Prednisolone—multiple sclerosis	0.000465	0.000879	CcSEcCtD
Eprosartan—Asthenia—Triamcinolone—multiple sclerosis	0.000464	0.000877	CcSEcCtD
Eprosartan—Abdominal pain—Betamethasone—multiple sclerosis	0.000463	0.000877	CcSEcCtD
Eprosartan—Abdominal pain—Dexamethasone—multiple sclerosis	0.000463	0.000877	CcSEcCtD
Eprosartan—Body temperature increased—Dexamethasone—multiple sclerosis	0.000463	0.000877	CcSEcCtD
Eprosartan—Body temperature increased—Betamethasone—multiple sclerosis	0.000463	0.000877	CcSEcCtD
Eprosartan—Asthenia—Methylprednisolone—multiple sclerosis	0.000463	0.000875	CcSEcCtD
Eprosartan—Insomnia—Prednisone—multiple sclerosis	0.000462	0.000874	CcSEcCtD
Eprosartan—Paraesthesia—Prednisone—multiple sclerosis	0.000458	0.000867	CcSEcCtD
Eprosartan—Pruritus—Triamcinolone—multiple sclerosis	0.000457	0.000865	CcSEcCtD
Eprosartan—Cough—Methotrexate—multiple sclerosis	0.000456	0.000863	CcSEcCtD
Eprosartan—Pruritus—Methylprednisolone—multiple sclerosis	0.000456	0.000863	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CCR1—multiple sclerosis	0.000452	0.00255	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000452	0.00255	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000451	0.00254	CbGpPWpGaD
Eprosartan—Dyspepsia—Prednisone—multiple sclerosis	0.000449	0.00085	CcSEcCtD
Eprosartan—Arthralgia—Methotrexate—multiple sclerosis	0.000445	0.000842	CcSEcCtD
Eprosartan—Chest pain—Methotrexate—multiple sclerosis	0.000445	0.000842	CcSEcCtD
Eprosartan—Myalgia—Methotrexate—multiple sclerosis	0.000445	0.000842	CcSEcCtD
Eprosartan—Decreased appetite—Prednisone—multiple sclerosis	0.000444	0.00084	CcSEcCtD
Eprosartan—Rash—Prednisolone—multiple sclerosis	0.000443	0.000838	CcSEcCtD
Eprosartan—Dermatitis—Prednisolone—multiple sclerosis	0.000443	0.000837	CcSEcCtD
Eprosartan—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000441	0.000835	CcSEcCtD
Eprosartan—Fatigue—Prednisone—multiple sclerosis	0.00044	0.000833	CcSEcCtD
Eprosartan—Headache—Prednisolone—multiple sclerosis	0.00044	0.000833	CcSEcCtD
Eprosartan—Discomfort—Methotrexate—multiple sclerosis	0.00044	0.000832	CcSEcCtD
Eprosartan—Constipation—Prednisone—multiple sclerosis	0.000437	0.000826	CcSEcCtD
Eprosartan—Dizziness—Triamcinolone—multiple sclerosis	0.000427	0.000808	CcSEcCtD
Eprosartan—Dizziness—Methylprednisolone—multiple sclerosis	0.000426	0.000807	CcSEcCtD
Eprosartan—Feeling abnormal—Prednisone—multiple sclerosis	0.000421	0.000796	CcSEcCtD
Eprosartan—Asthenia—Dexamethasone—multiple sclerosis	0.000421	0.000796	CcSEcCtD
Eprosartan—Asthenia—Betamethasone—multiple sclerosis	0.000421	0.000796	CcSEcCtD
Eprosartan—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000418	0.00079	CcSEcCtD
Eprosartan—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000417	0.00079	CcSEcCtD
Eprosartan—Nausea—Prednisolone—multiple sclerosis	0.000417	0.00079	CcSEcCtD
Eprosartan—Pruritus—Betamethasone—multiple sclerosis	0.000415	0.000785	CcSEcCtD
Eprosartan—Pruritus—Dexamethasone—multiple sclerosis	0.000415	0.000785	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—TAGAP—multiple sclerosis	0.000415	0.00233	CbGpPWpGaD
Eprosartan—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000412	0.00078	CcSEcCtD
Eprosartan—Vomiting—Triamcinolone—multiple sclerosis	0.000411	0.000777	CcSEcCtD
Eprosartan—Vomiting—Methylprednisolone—multiple sclerosis	0.00041	0.000775	CcSEcCtD
Eprosartan—Rash—Triamcinolone—multiple sclerosis	0.000407	0.000771	CcSEcCtD
Eprosartan—Dermatitis—Triamcinolone—multiple sclerosis	0.000407	0.00077	CcSEcCtD
Eprosartan—Anorexia—Methotrexate—multiple sclerosis	0.000407	0.000769	CcSEcCtD
Eprosartan—Rash—Methylprednisolone—multiple sclerosis	0.000406	0.000769	CcSEcCtD
Eprosartan—Dermatitis—Methylprednisolone—multiple sclerosis	0.000406	0.000768	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCL5—multiple sclerosis	0.000406	0.00229	CbGpPWpGaD
Eprosartan—Urticaria—Prednisone—multiple sclerosis	0.000406	0.000767	CcSEcCtD
Eprosartan—Headache—Triamcinolone—multiple sclerosis	0.000405	0.000766	CcSEcCtD
Eprosartan—Headache—Methylprednisolone—multiple sclerosis	0.000404	0.000764	CcSEcCtD
Eprosartan—Body temperature increased—Prednisone—multiple sclerosis	0.000404	0.000764	CcSEcCtD
Eprosartan—Abdominal pain—Prednisone—multiple sclerosis	0.000404	0.000764	CcSEcCtD
Eprosartan—Diarrhoea—Dexamethasone—multiple sclerosis	0.000401	0.000759	CcSEcCtD
Eprosartan—Diarrhoea—Betamethasone—multiple sclerosis	0.000401	0.000759	CcSEcCtD
Eprosartan—Hypotension—Methotrexate—multiple sclerosis	0.000399	0.000754	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000396	0.00223	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000389	0.000735	CcSEcCtD
Eprosartan—Dizziness—Dexamethasone—multiple sclerosis	0.000388	0.000733	CcSEcCtD
Eprosartan—Dizziness—Betamethasone—multiple sclerosis	0.000388	0.000733	CcSEcCtD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000386	0.00217	CbGpPWpGaD
Eprosartan—Insomnia—Methotrexate—multiple sclerosis	0.000386	0.00073	CcSEcCtD
Eprosartan—Nausea—Triamcinolone—multiple sclerosis	0.000384	0.000726	CcSEcCtD
Eprosartan—Paraesthesia—Methotrexate—multiple sclerosis	0.000383	0.000725	CcSEcCtD
Eprosartan—Nausea—Methylprednisolone—multiple sclerosis	0.000383	0.000724	CcSEcCtD
Eprosartan—Dyspnoea—Methotrexate—multiple sclerosis	0.00038	0.00072	CcSEcCtD
Eprosartan—Somnolence—Methotrexate—multiple sclerosis	0.000379	0.000718	CcSEcCtD
Eprosartan—Hypersensitivity—Prednisone—multiple sclerosis	0.000376	0.000712	CcSEcCtD
Eprosartan—Dyspepsia—Methotrexate—multiple sclerosis	0.000376	0.000711	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000375	0.00211	CbGpPWpGaD
Eprosartan—Vomiting—Dexamethasone—multiple sclerosis	0.000373	0.000705	CcSEcCtD
Eprosartan—Vomiting—Betamethasone—multiple sclerosis	0.000373	0.000705	CcSEcCtD
Eprosartan—Decreased appetite—Methotrexate—multiple sclerosis	0.000371	0.000702	CcSEcCtD
Eprosartan—Rash—Dexamethasone—multiple sclerosis	0.00037	0.000699	CcSEcCtD
Eprosartan—Rash—Betamethasone—multiple sclerosis	0.00037	0.000699	CcSEcCtD
Eprosartan—Dermatitis—Dexamethasone—multiple sclerosis	0.000369	0.000699	CcSEcCtD
Eprosartan—Dermatitis—Betamethasone—multiple sclerosis	0.000369	0.000699	CcSEcCtD
Eprosartan—Fatigue—Methotrexate—multiple sclerosis	0.000368	0.000696	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000367	0.00207	CbGpPWpGaD
Eprosartan—Headache—Dexamethasone—multiple sclerosis	0.000367	0.000695	CcSEcCtD
Eprosartan—Headache—Betamethasone—multiple sclerosis	0.000367	0.000695	CcSEcCtD
Eprosartan—Asthenia—Prednisone—multiple sclerosis	0.000366	0.000693	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCR5—multiple sclerosis	0.000366	0.00206	CbGpPWpGaD
Eprosartan—Pain—Methotrexate—multiple sclerosis	0.000365	0.00069	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—S1PR1—multiple sclerosis	0.000362	0.00204	CbGpPWpGaD
Eprosartan—Pruritus—Prednisone—multiple sclerosis	0.000361	0.000683	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—GPC5—multiple sclerosis	0.000352	0.00199	CbGpPWpGaD
Eprosartan—Feeling abnormal—Methotrexate—multiple sclerosis	0.000352	0.000665	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00035	0.00197	CbGpPWpGaD
Eprosartan—Diarrhoea—Prednisone—multiple sclerosis	0.000349	0.000661	CcSEcCtD
Eprosartan—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000349	0.00066	CcSEcCtD
Eprosartan—Nausea—Dexamethasone—multiple sclerosis	0.000348	0.000659	CcSEcCtD
Eprosartan—Nausea—Betamethasone—multiple sclerosis	0.000348	0.000659	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000342	0.00192	CbGpPWpGaD
Eprosartan—Urticaria—Methotrexate—multiple sclerosis	0.000339	0.000641	CcSEcCtD
Eprosartan—Dizziness—Prednisone—multiple sclerosis	0.000338	0.000639	CcSEcCtD
Eprosartan—Abdominal pain—Methotrexate—multiple sclerosis	0.000337	0.000638	CcSEcCtD
Eprosartan—Body temperature increased—Methotrexate—multiple sclerosis	0.000337	0.000638	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00033	0.00186	CbGpPWpGaD
Eprosartan—Vomiting—Prednisone—multiple sclerosis	0.000325	0.000614	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CCL3—multiple sclerosis	0.000322	0.00181	CbGpPWpGaD
Eprosartan—Rash—Prednisone—multiple sclerosis	0.000322	0.000609	CcSEcCtD
Eprosartan—Dermatitis—Prednisone—multiple sclerosis	0.000322	0.000608	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000321	0.00181	CbGpPWpGaD
Eprosartan—Headache—Prednisone—multiple sclerosis	0.00032	0.000605	CcSEcCtD
Eprosartan—Hypersensitivity—Methotrexate—multiple sclerosis	0.000314	0.000595	CcSEcCtD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000313	0.00176	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PTGER4—multiple sclerosis	0.00031	0.00175	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RGS1—multiple sclerosis	0.000308	0.00174	CbGpPWpGaD
Eprosartan—Asthenia—Methotrexate—multiple sclerosis	0.000306	0.000579	CcSEcCtD
Eprosartan—Nausea—Prednisone—multiple sclerosis	0.000303	0.000574	CcSEcCtD
Eprosartan—Pruritus—Methotrexate—multiple sclerosis	0.000302	0.000571	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CXCR3—multiple sclerosis	0.0003	0.00169	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000296	0.00167	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GPR65—multiple sclerosis	0.000292	0.00164	CbGpPWpGaD
Eprosartan—Diarrhoea—Methotrexate—multiple sclerosis	0.000292	0.000552	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CCR2—multiple sclerosis	0.000291	0.00164	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000287	0.00162	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—POMC—multiple sclerosis	0.000286	0.00161	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000284	0.0016	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000284	0.0016	CbGpPWpGaD
Eprosartan—Dizziness—Methotrexate—multiple sclerosis	0.000282	0.000534	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCL2—multiple sclerosis	0.00028	0.00158	CbGpPWpGaD
Eprosartan—Vomiting—Methotrexate—multiple sclerosis	0.000271	0.000513	CcSEcCtD
Eprosartan—Rash—Methotrexate—multiple sclerosis	0.000269	0.000509	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CNR1—multiple sclerosis	0.000269	0.00151	CbGpPWpGaD
Eprosartan—Dermatitis—Methotrexate—multiple sclerosis	0.000269	0.000509	CcSEcCtD
Eprosartan—Headache—Methotrexate—multiple sclerosis	0.000267	0.000506	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—CXCL13—multiple sclerosis	0.000267	0.0015	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR1—multiple sclerosis	0.000267	0.0015	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000267	0.0015	CbGpPWpGaD
Eprosartan—Nausea—Methotrexate—multiple sclerosis	0.000253	0.00048	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	0.000249	0.0014	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000242	0.00136	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000229	0.00129	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00022	0.00124	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL5—multiple sclerosis	0.000208	0.00117	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000207	0.00116	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000204	0.00115	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL3—multiple sclerosis	0.00019	0.00107	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR5—multiple sclerosis	0.000188	0.00106	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000185	0.00104	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTGER4—multiple sclerosis	0.000183	0.00103	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PGR—multiple sclerosis	0.00018	0.00102	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SRM—multiple sclerosis	0.000179	0.00101	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCR3—multiple sclerosis	0.000177	0.000997	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CD28—multiple sclerosis	0.000175	0.000987	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR2—multiple sclerosis	0.000172	0.000969	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—POMC—multiple sclerosis	0.000166	0.000936	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—POMC—multiple sclerosis	0.000162	0.00091	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CNR1—multiple sclerosis	0.000159	0.000895	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—POMC—multiple sclerosis	0.000147	0.000826	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL2—multiple sclerosis	0.000144	0.000809	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL10—multiple sclerosis	0.000143	0.000806	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TYK2—multiple sclerosis	0.00013	0.000734	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	0.000126	0.000712	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	0.000126	0.000712	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000126	0.000709	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CD86—multiple sclerosis	0.000125	0.000704	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000123	0.000696	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL5—multiple sclerosis	0.000123	0.000693	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL2—multiple sclerosis	0.000119	0.000673	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GPC5—multiple sclerosis	0.000116	0.000651	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SPP1—multiple sclerosis	0.000114	0.000642	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR5—multiple sclerosis	0.000111	0.000625	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2RA—multiple sclerosis	0.000109	0.000616	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL2—multiple sclerosis	0.000108	0.000611	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOE—multiple sclerosis	0.000101	0.000568	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—RRM1—multiple sclerosis	9.58e-05	0.000539	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CD80—multiple sclerosis	9.12e-05	0.000514	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—POMC—multiple sclerosis	8.67e-05	0.000488	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL2—multiple sclerosis	8.48e-05	0.000478	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MAPK1—multiple sclerosis	8.3e-05	0.000467	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TYK2—multiple sclerosis	7.7e-05	0.000434	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.43e-05	0.000418	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2—multiple sclerosis	6.41e-05	0.000361	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.38e-05	0.000359	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—multiple sclerosis	6.38e-05	0.000359	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—multiple sclerosis	6.07e-05	0.000342	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.82e-05	0.000328	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—BCHE—multiple sclerosis	5.5e-05	0.00031	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—STAT3—multiple sclerosis	5.39e-05	0.000304	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MYC—multiple sclerosis	5.01e-05	0.000282	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—multiple sclerosis	5e-05	0.000282	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAPK1—multiple sclerosis	4.9e-05	0.000276	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—multiple sclerosis	3.77e-05	0.000212	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOE—multiple sclerosis	3.31e-05	0.000186	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—POMC—multiple sclerosis	2.84e-05	0.00016	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—multiple sclerosis	2.59e-05	0.000146	CbGpPWpGaD
